Valsartan vs non-RAAS treatment: effect on autoregulation of cerebral blood flow in isolated systolic hypertension.

Trial Profile

Valsartan vs non-RAAS treatment: effect on autoregulation of cerebral blood flow in isolated systolic hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Dec 2012

At a glance

  • Drugs Antihypertensives; Valsartan
  • Indications Isolated systolic hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top